4//SEC Filing
Goeltz II Robert C. 4
Accession 0001610717-26-000002
CIK 0001724521other
Filed
Jan 1, 7:00 PM ET
Accepted
Jan 2, 4:19 PM ET
Size
4.4 KB
Accession
0001610717-26-000002
Insider Transaction Report
Form 4
Goeltz II Robert C.
Chief Financial Officer
Transactions
- Sale
Common Stock
2025-12-31$23.38/sh−6,552$153,186→ 67,924 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
Documents
Issuer
Arcus Biosciences, Inc.
CIK 0001724521
Entity typeother
Related Parties
1- filerCIK 0001653881
Filing Metadata
- Form type
- 4
- Filed
- Jan 1, 7:00 PM ET
- Accepted
- Jan 2, 4:19 PM ET
- Size
- 4.4 KB